Company: TUTH
Filing Date: 2025-10-01
Form Type: 1-SA
Source: 0001683168-25-007356
Chunk: 21

Company: Standard Dental Labs Inc.
Filing Date: 2025-10-01
Form: 1-SA
Chunk 21
---
 data presented in these financial statements have been adjusted to reflect
the reverse stock split.

During the six months ended June
30, 2025, the Company issued 1,889,612 (2024 - 0) shares as a result of convertible note conversions.

As of June 30, 2025, the Company
had 32,337,430 (December 31, 2024 - 30,447,818) common shares issued and outstanding.

Note 8 – Earnings (Loss) per Share

Basic earnings (loss) per share is computed
by dividing net income (loss) attributable to common shareholders by the weighted average number of common shares outstanding during the
period. Diluted earnings (loss) per share is computed by including potentially dilutive securities, such as convertible instruments and
stock options, using the treasury stock or if-converted method, as applicable. For the three and six months ended June 30, 2025 and 2024,
all such instruments were anti-dilutive and have been excluded from the computation of diluted loss per share and the earnings (loss)
per share was ($0.01) (2024 – ($0.01))

| F-8 |

STANDARD DENTAL LABS INC.

(formerly Costas, Inc.)

Notes to the Condensed Interim Financial Statements

for the three and six months ended June 30, 2025 and 2024

(Unaudited – Expressed in United States dollars)

Note 9 – Commitments and Contingencies

As of June 30, 2025, the Company did
not have any material commitments for capital expenditures.

However, the Company maintains several
contractual and operational arrangements that could give rise to future obligations, including:

| · | A services agreement with                                                                                                                     
 the contracted operator of the Company’s Orlando-based dental laboratory, as discussed in Note 8 of the annual Financial Statements,          
 which is subject to six months’ termination notice.                                                                                           |
| · | Convertible notes issued                                                                                                                      
 to related and third-party investors, which contain embedded features that may trigger conversion or settlement depending on future financing 
 events or maturity. If exercised, these features could result in the issuance of additional common shares, potentially diluting existing      
 shareholders, or, in certain cases, require cash settlement.                                                                                  |
| · | Ongoing legal and regulatory                                                                                                                  
 compliance expenses associated with preparing for a potential Regulation A Tier 2 offering.                                                   |

Management has assessed